Broncochem Syrup
NDC Package 65131-100-91

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Broncochem (dextromethorphan hbr-gyaifenesin) syrups is temporarily relieves cough due to minor throat and bronchial irritation occuring with common cold.Helps loosen phlegm (mucus) and dilute bronchial secretions to make coughs more productive.This new formulation with aloe results a natural cleanser, penetrates tissue, bactericidal, viruscidal, and fungicidal, enhances normal cell proliferation and moisturizes tissues (this statements are not yet evaluated by the Food and Drugs Administration "FDA")Broncochem Maximum Cough has not drowsiness effect.Work in chest congestion, its specially formulated for children and adults. This formulation utilizes a syrup delivery system. Marketed by Laboratorio Magnachem International Srl, this product is identified by NDC 65131-100 and is authorized under FDA application M.

Identification & Billing

NDC Package Code
65131-100-91
Package Description
1 BOTTLE, PLASTIC in 1 BOX / 120 mL in 1 BOTTLE, PLASTIC
Product Code
65131-100
11-Digit Billing Format
65131010091
RxNorm Crosswalk
  • RxCUI: 1046631 - dextromethorphan HBr 20 MG / guaiFENesin 400 MG in 10 mL Oral Solution
  • RxCUI: 1046631 - dextromethorphan hydrobromide 2 MG/ML / guaifenesin 40 MG/ML Oral Solution
  • RxCUI: 1046631 - dextromethorphan HBr 10 MG / guaifenesin 200 MG per 5 ML Oral Solution
  • RxCUI: 1046631 - dextromethorphan HBr 20 MG / guaifenesin 400 MG per 10 ML Oral Solution

Clinical Specifications

Proprietary Name
Broncochem Maximum Cough
Non-Proprietary Name
Dextromethorphan Hbr-gyaifenesin
Substance Name
Dextromethorphan Hydrobromide; Guaifenesin
Dosage Form
Syrup - An oral solution containing high concentrations of sucrose or other sugars; the term has also been used to include any other liquid dosage form prepared in a sweet and viscid vehicle, including oral suspensions.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Temporarily relieves cough due to minor throat and bronchial irritation occuring with common cold.Helps loosen phlegm (mucus) and dilute bronchial secretions to make coughs more productive.This new formulation with aloe results a natural cleanser, penetrates tissue, bactericidal, viruscidal, and fungicidal, enhances normal cell proliferation and moisturizes tissues (this statements are not yet evaluated by the Food and Drugs Administration "FDA")Broncochem Maximum Cough has not drowsiness effect.Work in chest congestion, its specially formulated for children and adults.

Regulatory & Marketing

Labeler Name
Laboratorio Magnachem International Srl
Product Type
Human Otc Drug
FDA Application #
M
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
04-21-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 65131-100-91 identifies a specific commercial package of 1 bottle, plastic in 1 box / 120 ml in 1 bottle, plastic of Broncochem Maximum Cough, a human over the counter drug labeled by Laboratorio Magnachem International Srl. This syrup is formulated for oral use and contains dextromethorphan hydrobromide; guaifenesin as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Laboratorio Magnachem International Srl on April 21, 2025. The current certification is valid through December 31, 2026.

How is this Laboratorio Magnachem International Srl product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 65131010091. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
65131-100-91
11-Digit CMS (5-4-2)
65131-0100-91

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.